| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8775225 | Seminars in Nephrology | 2017 | 8 Pages |
Abstract
Summary: The association of variants in the APOL1 gene, which encodes apolipoprotein L1 (APOL1), with progressive nondiabetic kidney diseases in African Americans has prompted intense investigation into the function(s) of APOL1. APOL1 is an innate immune effector that protects human beings from infection by some trypanosomal parasites. We review the data characterizing APOL1 trypanolytic function, which has been a basis for studies of APOL1 function in mammalian cells. Subsequently, we discuss the studies that use animal models, mammalian cell culture models, and kidney biopsy tissue to discover the mechanisms of variant APOL1-associated kidney diseases.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
John F. MD, Leslie A. PhD, Sethu MD, John R. MD,